Arifin Budiman Budiman Nugraha

Dr. Arifin Budiman Budiman Nugraha


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in Molecules
Verified
Journal Article
Open access
PDF file
Gaber El-Saber BatihaGaber El-Saber Batiha
Gaber El-Saber Batiha
ABAmany Magdy Beshbishy
Amany Magdy Beshbishy
AGAzirwan Guswanto
Azirwan Guswanto
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
TMTserendorj Munkhjargal
Tserendorj Munkhjargal
Ikuo IgarashiIkuo Igarashi
Ikuo Igarashi
Cinnamomum verum is a commonly used herbal plant that has several documented properties against various diseases. The existing study evaluated the inhibitory effect of acetonic extract of C. verum (AECV) and ethyl acetate extract of C. verum (EAECV) against piroplasm parasites in vitro and in vivo. The drug-exposure viability assay was tested on Madin-Darby bovine kidney (MDBK), mouse embryonic fibroblast (NIH/3T3) and human foreskin fibroblast (HFF) cells. Qualitative phytochemical estimation revealed that AECV and EAECV containing multiple bioactive constituents namely alkaloids, tannins, saponins, terpenoids and remarkable amounts of polyphenols and flavonoids. AECV and EAECV inhibited B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi multiplication at half-maximal inhibitory concentrations (IC50) of 23.1 ± 1.4, 56.6 ± 9.1, 33.4 ± 2.1, 40.3 ± 7.5, 18.8 ± 1.6 µg/mL, and 40.1 ± 8.5, 55.6 ± 1.1, 45.7 ± 1.9, 50.2 ± 6.2, and 61.5 ± 5.2 µg/mL, respectively. In the cytotoxicity assay, AECV and EAECV affected the viability of MDBK, NIH/3T3 and HFF cells with half-maximum effective concentrations (EC50) of 440 ± 10.6, 816 ± 12.7 and 914 ± 12.2 µg/mL and 376 ± 11.2, 610 ± 7.7 and 790 ± 12.4 µg/mL, respectively. The in vivo experiment showed that AECV and EAECV were effective against B. microti in mice at 150 mg/kg. These results showed that C. verum extracts are potential antipiroplasm drugs after further studies in some clinical cases.

1 September 2018 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
DTDickson Tayebwa
Dickson Tayebwa
PVPatrick Vudriko
Patrick Vudriko
BTBumduuren Tuvshintulga
Bumduuren Tuvshintulga
AGAzirwan Guswanto
Azirwan Guswanto
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
Ikuo IgarashiIkuo Igarashi
Ikuo Igarashi

1 July 2018 in Ticks and Tick-borne Diseases
Verified
Journal Article
Closed access
DTDickson Tayebwa
Dickson Tayebwa
BTBumduuren Tuvshintulga
Bumduuren Tuvshintulga
AGAzirwan Guswanto
Azirwan Guswanto
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
Gaber El-Saber BatihaGaber El-Saber Batiha
Gaber El-Saber Batiha
Ikuo IgarashiIkuo Igarashi
Ikuo Igarashi

1 April 2018 in International Journal for Parasitology: Drugs and Drug Resistance
Verified
Journal Article
Open access
AGAzirwan Guswanto
Azirwan Guswanto
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
BTBumduuren Tuvshintulga
Bumduuren Tuvshintulga
DTDickson Tayebwa
Dickson Tayebwa
Mohamed RizkMohamed Rizk
Mohamed Rizk
Ikuo IgarashiIkuo Igarashi
Ikuo Igarashi
Heat shock protein 90 (Hsp90) is a chaperone protein that stabilizes cells during stress or non-stress responses. Previous reports have shown that Hsp90 is a potential drug target to suppress the multiplication of several protozoan parasites. In this study, 17-dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG), an Hsp90 inhibitor, was evaluated for its inhibitory effect on five in vitro cultures of Babesia and Theileria species, including B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi, and on the multiplication of a B. microti-infected mouse model. 17-DMAG showed the inhibitory effect in all of the species tested. The half maximum inhibition concentration (IC50) of 17-DMAG on B. bovis, B. bigemina, B. divergens, B. caballi, and T. equi was 77.6 ± 2.9, 62.4 ± 1.9, 183.8 ± 3.2, 88.5 ± 9.6, and 307.7 ± 7.2 nM, respectively. The toxicity assay on MDBK and NIH/3T3 cell lines showed that 17-DMAG affected the viability of cells with an IC50 of 15.5 ± 4 and 8.8 ± 2 μM, respectively. Since the IC50s were much lower on the parasites than on the host cell lines, the selectivity index were high for all tested species. Furthermore, the two-drug combination of 17-DMAG with diminazene aceturate (DA) and atovaquone (AV) showed synergism or addition on in vitro cultures of Babesia and Theileria parasites. In the mouse model, 17-DMAG at a concentration of 30 mg/kg BW effectively inhibited the multiplication of B. microti. Moreover, if combined with DA or AV, 17-DMAG showed a comparable inhibition at the half dose. Taken together, these results indicate that 17-DMAG is a potent drug for treating piroplamosis. The data warrant further evaluation of 17-DMAG as an antibabesial drug and as an option in combination with atovaquone for the treatment of human babesiosis.

20 July 2020 in Parasites & Vectors
Verified
Journal Article
Open access
PDF file
LCLeonardo Jose de Moura Carvalho
Leonardo Jose de Moura Carvalho
BTBunduurem Tuvshintulga
Bunduurem Tuvshintulga
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
TSThillaiampalam Sivakumar
Thillaiampalam Sivakumar
NYNaoaki Yokoyama
Naoaki Yokoyama
Background: Babesiosis represents a veterinary and medical threat, with a need for novel drugs. Artemisinin-based combination therapies (ACT) have been successfully implemented for malaria, a human disease caused by related parasites, Plasmodium spp. The aim of this study was to investigate whether ACT is active against Babesia in vitro and in vivo. Methods: Mefloquine, tafenoquine, primaquine, methylene blue and lumefantrine, alone or in combination with artesunate, were tested in vitro against Babesia bovis. Parasite growth was verified using a SYBR green I-based fluorescence assay. Mice infected with Babesia microti were treated with mefloquine or tafenoquine, alone or in combination with artesunate, and parasitemia was verified by microscopy and PCR. Results: All drugs, except lumefantrine, showed in vitro activity against B. bovis, with methylene blue showing the most potent activity (concentration 0.2 μM). Combination with artesunate led to improved activity, with mefloquine showing a striking 20-fold increase in activity. Tafenoquine (10 mg/kg, base), combined or not with artesunate, but not mefloquine, induced rapid clearance of B. microti in vivo by microscopy, but mice remained PCR-positive. Blood from mice treated with tafenoquine alone, but not with tafenoquine-artesunate, was infective for naive mice upon sub-inoculation. Conclusions: Tafenoquine, and most likely other 8-aminoquinoline compounds, are promising compounds for the development of ACT for babesiosis.

1 December 2023 in Jurnal Sain Veteriner
Verified
Journal Article
Open access
PDF file
NRNisrina Rosyida Noor Rifai
Nisrina Rosyida Noor Rifai
ANArifin Budiman Budiman Nugraha
Arifin Budiman Budiman Nugraha
EHEkowati Handharyani
Ekowati Handharyani
FKFajar Kawitan
Fajar Kawitan
UCUmi Cahyaningsih
Umi Cahyaningsih
Bearded dragons are reptiles that are quite popular as pets. There are many factors of disease that can infect bearded dragons. The environment and feed affect the level of disease threat, such as parasitic infection in the gastrointestinal tract. Data information related to parasitic gastrointestinal infections in bearded dragons in Indonesia is still limited, so supporting examinations are necessary to help diagnose. A total of 38 fecal samples were collected from the bearded dragon in Cijeruk Bogor. Samples were examined by simple flotation method, Ziehl Neelsen staining, and counting the number of parasitic eggs. All samples were positive for gastrointestinal parasite infections such as Choleoeimeria sp., Isospora amphiboluri, Cryptosporidium spp., ascarid egg, and oxyurid egg. The average number of Choleoeimeria sp. and Isospora amphiboluri oocysts were 8730 and 51.281 oocysts per gram of feces. The average number of helminth eggs per gram was 290 and 2325 for ascarid and oxyurid, respectively. Most of the infected bearded dragons do not show significant clinical symptoms. The number of oocysts and worm eggs per gram of feces showed mild and high results.